How PBPK Modeling Can Replace Drug-Drug Interaction Studies
Patients often take more than one drug at a time, especially elderly patients and those…
Certara2020 年 11 月 12 日
Certara Opens New China Office in Shanghai
Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …
Certara2020 年 11 月 9 日
PBPK modeling supports approval of breakthrough cancer drug
Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US…
Certara2020 年 10 月 23 日
